Capula Management LTD Exact Sciences Corp Transaction History

Capula Management LTD

  • $9.23 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$30.35 - $53.15 $128,866 - $225,674
4,246 New
4,246 $210,000
Q4 2021

Feb 14, 2022
SELL
$72.5 - $100.68 $1.07 Million - $1.49 Million
-14,767 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$90.24 - $124.05 $1.33 Million - $1.83 Million
14,767 New
14,767 $1.41 Million

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Capula Management LTD Portfolio

Follow Capula Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Capula Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email